최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.23 no.5 = no.157, 2013년, pp.703 - 709
이민혁 (순천대학교 생물학과) , 황영민 (순천대학교 생물학과) , 백근식 (순천대학교 생물학과) , 조현욱 (순천대학교 생물학과) , 성치남 (순천대학교 생물학과)
The aim of this study was to investigate the prevalence of Extended-spectrum
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
Extended-spectrum β-lactamase는 무엇입니까? | Extended-spectrum β-lactamase (ESBL)는 plasmid 매개 효소로서 β-lactam환을 가수분해하여 oxyimino-β-lactam 항생제에 대해 내성을 갖게 한다[9]. 즉, ESBL은 penicillin과 1, 3, 4세대 cephalosporin계열 및 monobactam계열의 aztreonam까지 분해한다[11]. | |
한국에서 2002년 전국 13개 병원을 대상으로 조사한 ESBL 출현 현황은? | ESBL의 여러 가지 유전자형 중 SHV, TEM, CTX-M 등이 널리 보고 되고 있다. 국내에서도 2002년 전국 13개 병원을 대상으로 조사한 ESBL 출현 현황에서 E. coli와 K. pneumoniae가 CTX-M (CTX-M-3, CTX-M-14, CTX-M-15) 유전자를 보유하고 있다고 하였다[2, 21]. | |
Extended-spectrum β-lactamase는 어떤 분류에 속하는 효소입니까? | 즉, ESBL은 penicillin과 1, 3, 4세대 cephalosporin계열 및 monobactam계열의 aztreonam까지 분해한다[11]. ESBL은 기질 특이성, β-lactamase 저해제에 의한 효소 활성 억제 정도 등에 따른 분류에서는 group 2be에, 분자구조에 따른 분류에서는 class A에 속한다[3]. |
Antimicrobial resistance newsletter. 2006. Antimicrobial resistance of clinical isolates of bacteria in 2005. Ser. No.52.
Bae, I. K., Woo, G. J., Jeong, S. H., Park, K. O., Cho, B. K., Kim, D. M., Kwon, S. B., Kim, H. J. and Kang, H. K. 2004. Prevalence of CTX-M-type extended-spectrum $\beta$ -lactamase producing Esherichia coli and Klebsiella pneumoniae isolates in Korea. Korean J Clin Microbiol 7, 48-54.
Bush, K., Jacoby, G. A. and Medeiros, A. A. 1995. A functional classification scheme for $\beta$ -lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39, 1211-1233.
Canton, R. and Coque, T. M. 2006. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 9, 466-475.
Garau, J., Xercavins, M., Rodriguez-Carballeira, M., Gomez-Vera, J. R., Coll, I., Vidal, D., Llovet, T. and Ruiz-Bremon, A. 1999. Emergence and dissemination of quinolone- resistance Escherichia coli in the community. Antimicrob Agents Chemother 43, 2736-2741.
Hassan, W. M., Hashim, A. and Domany, R. 2012. Plasmid mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qep in ESBL-producing Escherichia coli clinical isolates from Egypt. Indian J Med Microbiol 30, 442-447.
Hong, J. S., Bae, I. K., Song, E. H., Jeong, S. H., Lee, K. W., Yong, D. E., Lee, J. W., Lee, W. G., Kang, J. O., Ahn, J. Y., Hong, S. K., Shin, J. H., Uh, Y., Park, Y. J., Kim, E. C., Kwak, H. S. and Woo, G. J. 2005. Dissemination of CTX-M type extended-spectrum $\beta$ -lactamases and emergence of CTX-M-12 in Escherichia coli. Korean J Lab Med 25, 252-258.
Hwang, H. Y., Park, J. S., Bae, I. K., Lee, Y. N. and Jeong, S. H. 2007. Escherichia coli producing CTX-M extended- spectrum $\beta$ -lactamase. Kosin Med J 22, 58-67.
Jacoby, G. A. and Medeiros, A. A. 1991. More extended- spectrum $\beta$ -lactamases. Antimicrob Agents Chemother 35, 1697-1704.
Jacoby, G. A., Chow, N. and Waites, K. B. 2003. Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother 47, 559-562.
Jacoby, G. A. 2006. $\beta$ -Lactamase nomenclature. Antimicrob Agents Chemother 50, 1123-1129.
Jeong, H. S., Bae, I. K., Shin, J. H., Jung, H. J., Kim, S. H., Lee, J. Y., Oh, S. H., Kim, H. R., Chang, C. L., Kho, W. G. and Lee, J. N. 2011. Prevalence of plasmid-mediated quinolone resistance and its association with extended- spectrum beta-lactamase and AmpC beta-lactamase in Enterobacteriaceae Korean J Lab Med 31, 257-264.
Jeong, S. H., Bae, I. K., Kwon, S. B., Lee, J. H., Song, J. S., Jung, H. I., Sung, K. H., Jang, S. J. and Lee, S. H. 2005. Dissemination of transferable CTX-M-type extended- spectrum $\beta$ -lactamase-producing Escherichia coli in Korea. J Appl Microbiol 98, 921-927.
Kang, H. K. 2008. Prevalence of qnr genes among clinical isolates of Escherichia coli producing extended-spectrum $\beta$ -lactamase from Korea. Ph.D. Thesis. Kosin University. Korea.
Kim, Y. J., Seo, M. R., Kim, J., Choi, E. H., Lee, H. J. and Pai, H. J. 2009. Prevalence and characterization of plasmid- mediated quinolone resistance genes among clinical isolates of extended-spectrum cephalosporin resistant Enterobacter cloacae. Infec Chemother 41, 279-285.
Kjerulf, A., Hansen, D. S., Sandvang, D., Hansen, F. and Frimodt-Møller, N. 2008. The prevalence of ESBL-producing E. coli and Klebsiella strains in the Copenhagen area of Denmark. APMIS 116, 118-124.
Lee, C. C., Lui, G., Ip, M., Ling, T. K. and Lee, N. 2012. Frequent detection of plasmid-mediated quinolone resistance (qnr) genes in multidrug-resistant Enterobacteriaceae blood isolates, Hong Kong. Eur J Clin Microbiol Infect Dis 31, 3183-3189.
Lee, G. S. 2004. Patterns of antimicrobial resistance and genotyping of extended spectrum $\beta$ -Lactamase (ESBL) producing clinical isolates in Korea. M.Sc. Thesis. Yonsei University, Korea.
Munshi, M. H., Sack, D. A., Haider, K., Ahmed, Z. U., Rahaman, M. M. and Morshed, M. G. 1987. Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1. Lancet 2, 419-421. 1. Lancet 2, 419-421.
National Committee for Clinical Laboratory Standards. 1993. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2- A5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
Pai, H., Choi, E. H., Lee, H. J., Hong, J. Y. and Jacoby, G. A. 2001. Identification of CTX-M-14 extended-spectrum $\beta$ -lactamase in clinical isolates of Shigella sonnei, Escherichia coli, Klebsiella pneumoniae in Korea. J Clin Microbiol 39, 3747-3749.
Park, J. H., Lee, S. H., Jeong, S. H., Kim, B. N., Kim, K. B., Yoon, J. D. and Jeon, B. C. 2003. Characterization and prevalence of Escherichia coli and Klebsiella pneumoniae isolates producing an extended-spectrum $\beta$ -lactamase from Korean hospitals. Korean J Lab Med 23, 18-24.
Park, J. H., Lee, S. H., Jeong, S. H., Kim, K. B., Yoon, J. D. and Jeon, B. C. 2003. Charaterization and prevalence of Escherichia coli and Klebsiela pneumoniae isolate producing an extended-spectrum $\beta$ -lactamase from Korea hospital. Korea J Med 23, 18-20.
Philippon, A., Labia, R. and Jacoby, G. A. 1989. Extended-spectrum $\beta$ -lactamases. Antimicrob Agents Chemother 33, 1131-1136.
Robicsek, A., Jacoby, G. A. and Hooper, D. C. 2006. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 6, 629-640.
Sanders, C. C., Barry, A. L., Washington, J. A., Shubert, C., Moland, E. S., Traczewski, M. M., Knapp, C. and Mulder, R. 1996. Detection of extended-spectrum- $\beta$ -lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test. J Clin Microbiol 34, 2997-3001.
Sanders, C. C. and Sanders, W. E. Jr. 1992. $\beta$ -Lactam resistance in Gram negative bacteria: global trends and clinical impact. Clin Infect Dis 15, 824-839.
Scheutz, F. and Strockbine, N. A. 2005. Genus I. Escherichia Castellani and Chalmers 1919, $941^{AL}$ . In Bergey's Manual of Systematic Bacteriology, The Proteobacteria, Part B: The Gammaproteobacteria, 2nd eds., vol. 2, pp. 607-625. In: Garrity, G., Brenner, D. J., Krieg, N. R. and Staley, J. R. (eds.), New York: Springer.
Wu, J. J., Ko, W. C., Tsai, S. H. and Yan, J. J. 2007. Prevalence of plasmid-mediated quinolone resistance determinants qnrA, qnrB, and qnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob Agents Chemother 51, 1223-1227.
Yoo, Y. 2008. In vitro susceptibility against piperacillin/ tazobactam and ESBL genotypes of Escherichia coli and Klebsiella pneumonia producing extended-spectrum $\beta$ - lactamase. M.Sc. Thesis. Konkuk University, Korea.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.